Home > Adults > Biochemistry >

Hyperlipidaemia

Checked: 08-08-2024 by Vicky Ryan Next Review: 02-06-2026

Lipid Guidelines

National Guidelines - interactive pathway

NICE have produced an interactive tool to guide clinicians through appropriate lipid management in primary care. This is a good starting point for most patients:

Summary of National Guidance for Lipid Management for Primary and Secondary Prevention of CVD

Local Guidelines

Local lipid specialists at UHBW/NBT have also worked with ICB pharmacy colleagues to produce a new bundle of detailed guidelines summarising the diagnosis and monitoring of lipid disorders.

The bundle seeks to standardise and consolidate lipid advice across both primary and secondary care. The bundle incorporates the NHS England national lipid management and statin intolerance pathways (adopted recently by the BNSSG APMOC group) as well as summaries on core topics such as:

Hypertriglyceridemia diagnosis and management
Lipoprotein (a) measurement and interpretation
Secondary prevention pathways
Non-statin/Ezetimibe therapies (including injectable technologies and Inclisiran)

The guidelines have been designed to consolidate guidance across several sources and be easily navigated by clinicians with algorithms. If you have any concerns about the content or presentation of the new bundle please get in contact with Dr Paul Downie/Dr Eloise Willis (paul.downie@uhbw.nhs.uk / eloise.willis@uhbw.nhs.uk) from the UHBW lipid clinic.

Specific guidelines

2. Cardiovascular System Guidelines

Please use the link above to access the guidelines in the BNSSG formulary which advises on the management of patients in primary care and when to consider referral

Referral

If criteria for referral to Lipid Clinic are met then please submit your referral via eRS (Under Endocrinology and Metabolic Medicine).

If advice is required then there is also the Lipid Advice & Guidance Service available via eRS.

Resources

Full Lipid Guidelines document - BNSSG lipid guidelines on the diagnosis and management of lipid disorders

Efforts are made to ensure the accuracy and agreement of these guidelines, including any content uploaded, referred to or linked to from the system. However, BNSSG ICB cannot guarantee this. This guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer, in accordance with the mental capacity act, and informed by the summary of product characteristics of any drugs they are considering. Practitioners are required to perform their duties in accordance with the law and their regulators and nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.

Information provided through Remedy is continually updated so please be aware any printed copies may quickly become out of date.